In summary, these data underscore the in vivo relevance of our conclusion drawn from the in vitro experiments, further strengthening our hypothesis that stroma-derived WNT2 is a prominent angiogenesis-promoting factor in colon cancer. The gene discussed is WNT2; the disease is malignant colon neoplasm.